ClinicalTrials.Veeva

Menu

Ovarian Hyperstimulation Syndrome (OHSS) Prevention With Agonist

U

University Hospital Schleswig-Holstein (UKSH)

Status

Completed

Conditions

Ovarian Hyperstimulation Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT00835523
OHSS 2009

Details and patient eligibility

About

The aim of the study is to explore the concept of GnRH-agonist triggering in combination with elective cryopreservation of all 2PN oocytes at larger scale in a pragmatic clinical setting. The question asked is: "Does GnRH-agonist triggering and cryopreservation work", in terms of efficacy and safety, when applied to a larger cohort of patients, and by a number of different centres with different clinical routines.

Enrollment

51 patients

Sex

All

Ages

18 to 39 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for IVF with ICSI
  • Age < 40 years
  • < 4 failed previous IVF attempts with embryo transfer
  • ovarian stimulation with GnRH-antagonist and gonadotrophins
  • >20 follicles >11 mm in mean diameter or E2 >4500 pg/ml on the day , on which it was planned to administer hCG
  • willing to participate and able to consent
  • patient has not previously received GnRH-agonist as a trigger of final oocyte maturation

Exclusion criteria

  • None

Trial design

51 participants in 1 patient group

OHSS risk

Trial contacts and locations

10

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems